Company Overview of Velcura Therapeutics Inc.
Velcura Therapeutics, Inc., a bone disease biotechnology company, develops therapies to restore bone homeostasis and bone health. It develops therapies for the treatment of bone diseases, such as rheumatoid arthritis, multiple myeloma, bone metastases, and osteoporosis. Velcura Therapeutics, Inc. has a strategic partnership with Nippon Chemiphar Co., Ltd. Velcura Therapeutics, Inc. was formerly known as Osteomics Inc. The company was founded in 2001 and is based in Ann Arbor, Michigan.
4300 Varsity Drive
Ann Arbor, MI 48108
Founded in 2001
Key Executives for Velcura Therapeutics Inc.
Similar Private Companies By Industry
|Immunovative Clinical Research, Inc.||United States|
|BioCee, Inc.||United States|
|Transcriptic, Inc||United States|
|Lehigh Nanotech, LLC||United States|
|Murex Diagnostics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Velcura Therapeutics Inc., please visit www.velcura.com. Company data is provided by Capital IQ. Please use this form to report any data issues.